
Fennec Pharmaceuticals CFO sells $153k in company stock
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Chief Financial Officer Robert Andrade has sold a total of $153,690 worth of company stock, according to a recent SEC filing. The transaction occurred on March 25, 2024, with the shares sold at a price of $10.9975 each. The recent sale by the CFO of Fennec Pharmaceuticals involved 13,975 shares of...